Microbix Biosystems Beheer
Beheer criteriumcontroles 3/4
De CEO Microbix Biosystems is Cameron Groome, benoemd in Jul2017, heeft een ambtstermijn van 7.33 jaar. De totale jaarlijkse vergoeding van { bedraagt CA$ 476.58K, bestaande uit 85.3% salaris en 14.7% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 2.05% van de aandelen van het bedrijf, ter waarde CA$ 861.40K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7.8 jaar en 17.8 jaar.
Belangrijke informatie
Cameron Groome
Algemeen directeur
CA$476.6k
Totale compensatie
| Percentage CEO-salaris | 85.3% |
| Dienstverband CEO | 7.3yrs |
| Eigendom CEO | 2.0% |
| Management gemiddelde ambtstermijn | 7.8yrs |
| Gemiddelde ambtstermijn bestuur | 17.8yrs |
Recente managementupdates
Recent updates
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution
Aug 22
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem
Feb 21Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price
Feb 17Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up
Dec 23Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?
Nov 03Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?
Jul 22Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio
May 17Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook
Dec 27Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet
Aug 08Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals
May 20Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly
Feb 06One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates
Dec 28Is Microbix Biosystems (TSE:MBX) A Risky Investment?
Oct 14Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 15A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)
May 17Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable
Mar 24We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt
Jan 29
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CA$5m |
| Mar 31 2024 | n/a | n/a | CA$4m |
| Dec 31 2023 | n/a | n/a | CA$4m |
| Sep 30 2023 | CA$477k | CA$406k | -CA$39k |
| Jun 30 2023 | n/a | n/a | -CA$3m |
| Mar 31 2023 | n/a | n/a | -CA$1m |
| Dec 31 2022 | n/a | n/a | -CA$391k |
| Sep 30 2022 | CA$537k | CA$388k | CA$2m |
| Jun 30 2022 | n/a | n/a | CA$3m |
| Mar 31 2022 | n/a | n/a | CA$4m |
| Dec 31 2021 | n/a | n/a | CA$4m |
| Sep 30 2021 | CA$598k | CA$311k | CA$3m |
| Jun 30 2021 | n/a | n/a | -CA$3m |
| Mar 31 2021 | n/a | n/a | -CA$4m |
| Dec 31 2020 | n/a | n/a | -CA$6m |
| Sep 30 2020 | CA$363k | CA$305k | -CA$6m |
| Jun 30 2020 | n/a | n/a | -CA$1m |
| Mar 31 2020 | n/a | n/a | -CA$1m |
| Dec 31 2019 | n/a | n/a | -CA$434k |
| Sep 30 2019 | CA$313k | CA$281k | CA$32k |
| Jun 30 2019 | n/a | n/a | -CA$8m |
| Mar 31 2019 | n/a | n/a | -CA$8m |
| Dec 31 2018 | n/a | n/a | -CA$9m |
| Sep 30 2018 | CA$306k | CA$250k | -CA$9m |
Compensatie versus markt: De totale vergoeding ($USD 341.19K ) Cameron } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 169.25K ).
Compensatie versus inkomsten: De vergoeding van Cameron is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Cameron Groome
7.3yrs
Tenure
CA$476,575
Compensatie
Mr. Cameron L. Groome is Director of Naegis Pharmaceuticals Inc. He serves as an Independent Director at iFabric Corp. since March 30, 2020. Mr. Groome has been the Chief Executive Officer and President of...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 7.3yrs | CA$476.58k | 2.05% CA$ 861.4k | |
| Chief Financial Officer | 7.8yrs | CA$312.52k | 0.20% CA$ 85.2k | |
| Chief Operating Officer | 5.4yrs | CA$312.58k | 0.34% CA$ 141.0k | |
| Senior Vice President of Scientific Affairs | 17yrs | CA$277.11k | 0.27% CA$ 114.5k | |
| Senior Vice President of Sales | 12yrs | CA$292.92k | 0.38% CA$ 161.6k | |
| Compliance Officer | no data | geen gegevens | geen gegevens |
7.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van MBX is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 12.7yrs | CA$476.58k | 2.05% CA$ 861.4k | |
| Independent Director | 22.1yrs | geen gegevens | 0.40% CA$ 170.2k | |
| Independent Director | 21.8yrs | geen gegevens | 6.96% CA$ 2.9m | |
| Independent Chairman of the Board | 15.8yrs | geen gegevens | 1.08% CA$ 454.4k | |
| Independent Director | 18.9yrs | geen gegevens | 2.07% CA$ 871.9k | |
| Independent Director | 17.8yrs | geen gegevens | 1.27% CA$ 531.8k | |
| Independent Director | 2.7yrs | geen gegevens | 0.010% CA$ 4.3k |
17.8yrs
Gemiddelde duur
Ervaren bestuur: De raad van bestuur van MBX zijn ervaren en ervaren (gemiddelde ambtstermijn van 17.8 jaar).